835 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
SNY Sanofi $42.07 $104.22B Uptrend
Article Searches
Biechele Royce Advisors Buys Procter & Gamble Co, Franklin Resources Inc, Sanofi SA, Sells ... http://www.gurufocus.com/news/710686/biechele-royce-advisors-buys-procter--gamble-co-franklin-resources-inc-sanofi-sa-sells-schlumberger-total-sa-patterson-inc Jul 20, 2018 - Biechele Royce Advisors Buys Procter & Gamble Co, Franklin Resources Inc, Sanofi SA, Sells Schlumberger, Total SA, Patterson Inc, Stocks: PG,SNY,UNP,SBUX,GLD,UPS,BEN,EPD,SLB,TOT,PDCO,MOS,, release date:Jul 20, 2018
6 European Stocks to Shun on Tapered IMF Outlook http://www.zacks.com/stock/news/312147/6-european-stocks-to-shun-on-tapered-imf-outlook?cid=CS-ZC-FT-312147 Jul 19, 2018 - IMF lowered its growth projection for in Germany, France and Italy. Time to avoid these sell-ranked stocks?
Aquestive Therapeutics Readies $60 Million IPO https://seekingalpha.com/article/4187487-aquestive-therapeutics-readies-60-million-ipo?source=feed_tag_ipo_analysis Jul 16, 2018 - Aquestive Therapeutics has filed amended terms for its $60 million U.S. IPO.The firm combines a manufacturing operation with a more recent development pipeline.AQST is pursuing an intriguing business
Constellation Pharmaceuticals Readies $80 Million IPO Plans https://seekingalpha.com/article/4186954-constellation-pharmaceuticals-readies-80-million-ipo-plans?source=feed_tag_ipo_analysis Jul 12, 2018 - Constellation Pharmaceuticals intends to sell $80 million of its common stock in a U.S. IPO.The firm is developing treatment candidates for a variety of cancers and myelofibrosis diseases.CNST has sho
A Wormhole View Of Voyager's Parkinson's Gene Therapy https://seekingalpha.com/article/4186427-wormhole-view-voyagers-parkinsons-gene-therapy?source=feed_sector_healthcare Jul 10, 2018 - The initial phase 1 trial results were comparable to several prior Parkinson's therapies that weren't approved. A large percentage of patients opted to undergo deep brain stimulation surgery relativel
Seth Klarman Declares Ownership of Fledgling Biotech http://www.gurufocus.com/news/706095/seth-klarman-declares-ownership-of-fledgling-biotech Jul 10, 2018 - Seth Klarman Declares Ownership of Fledgling Biotech, Stocks: TBIO,SNY, release date:Jul 10, 2018
Biotech Analysis Central Pharma News: Catabasis Nears Phase 3 Start, Regulus Slashes Workforce, Cytori's Mixed ED Data https://seekingalpha.com/article/4186242-biotech-analysis-central-pharma-news-catabasis-nears-phase-3-start-regulus-slashes-workforce?source=feed_sector_healthcare Jul 10, 2018 - Catabasis will soon launch a phase 3 study treating patients with DMD.Regulus Therapeutics pauses clinical studies and slashes 60% of workforce.Cytori Therapeutics announces phase 1 results for erecti
Learn How To Invest Against Acute Myeloid Leukemia, One Of The Fastest-Growing Cancer Markets https://seekingalpha.com/article/4185915-learn-invest-acute-myeloid-leukemia-one-fastest-growing-cancer-markets?source=feed_all_articles Jul 09, 2018 - Acute myeloid leukemia is the subject of major research and development.Investors interested in cancer should definitely be aware of AML and the ongoing developments.This article focuses on the basics
Regulus Stock Plunges on Cash Concerns Despite Restructuring http://www.zacks.com/stock/news/310672/regulus-stock-plunges-on-cash-concerns-despite-restructuring?cid=CS-ZC-FT-310672 Jul 09, 2018 - Regulus Therapeutics (RGLS) announces strategic and restructuring plans to extend cash runway. However, investors remain skeptical.
Week In Review: Suzhou Innovent Files For HK IPO - $500 Million Raise Rumored https://seekingalpha.com/article/4185917-week-review-suzhou-innovent-files-hk-ipo-500-million-raise-rumored?source=feed_all_articles Jul 08, 2018 - Deals and Financings Innovent Biologics of Suzhou has filed to IPO on the Hong Kong Exchange under its new rules for pre-revenue biopharmas. The company plans to raise as much as $500 million, accordi

Pages: 123456...84

Page 1>

Related Companies

Name Exchange Price Mkt Cap
GSK GlaxoSmithKline PLC NYSE $40.97 $101.6B
LLY Eli Lilly and Company NYSE $90.03 $97.72B
ABT Abbott Laboratories NYSE $64.75 $113.52B
AZN Astrazeneca PLC NYSE $37.33 $94.57B
BMY Bristol-Myers Squibb Company NYSE $56.88 $92.97B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Sanofi
SNY - Google Finance https://www.google.com/finance?q=SNY Industry related info and international coverage Summary News
SNY - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=SNY Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options